Monoclonal antibody therapeutics for pandemic preparedness
Title: Monoclonal antibody therapeutics for pandemic preparedness
Speaker: Dr Wen Shi Lee from the Peter Doherty Institute for Infection and Immunity, University of Melbourne
Abstract: In this seminar, he will describe his recent and ongoing work isolating neutralising mAbs against henipaviruses and flaviviruses from vaccinated and convalescent humans. He will also present an alternative approach to deliver monoclonal antibodies via mRNA-lipid nanoparticles, with demonstrated protective efficacy against influenza and SARS-CoV-2.
Bio: Dr Wen Shi Lee is a senior research officer in the Viral Vax Laboratory at the Peter Doherty Institute for Infection and Immunity, University of Melbourne. He was awarded his PhD in 2019, focusing on understanding the role of antibody Fc effector functions in HIV cure approaches. More recently, he expanded his research program to investigate neutralising antibody responses following COVID-19 vaccination and infection. He now leads a group developing monoclonal antibody (mAb) therapeutics against viral pathogens of pandemic potential, including henipaviruses, flaviviruses and poxviruses.
About School research seminars
Seminars cover all aspects of chemistry and molecular biosciences and are delivered by visiting national and international academics. PhD completion seminars are also incorporated into the program.
Seminars are usually held in person and occasionally via zoom. All are welcome to attend.
Contacts
- Chemistry: A/Prof Rowan Young, Dr David Cantillo
- Molecular Biosciences: Dr Rhys Parry, Dr Chris McMillan